The North American Neuroendocrine Society (NANETS) Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors

There have been significant developments in diagnostic and therapeutic options for patients with neuroendocrine tumors. Key phase III studies include the CLARINET trial which evaluated lanreotide in patients with non-functioning enteropancreatic NETs, the RADIANT 2 and RADIANT 4 studies, which evalu...

詳細記述

保存先:
書誌詳細
出版年:Pancreas
主要な著者: Strosberg, Jonathan R., Halfdanarson, Thorvardur R., Bellizzi, Andrew M., Chan, Jennifer A., Dillon, Joseph, Heaney, Anthony P., Kunz, Pamela L., O’Dorisio, Thomas M., Salem, Riad, Segelov, Eva, Howe, James, Pommier, Rodney, Brendtro, Kari, Bashir, Mohammad, Singh, Simron, Soulen, Michael C., Tang, Laura, Zacks, Jerome S., Yao, James, Bergsland, Emily
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5642985/
https://ncbi.nlm.nih.gov/pubmed/28609356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000000850
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料